- Home
- QNCX vs FABC Comparison
QNCX vs FABC Comparison
Compare QNCX & FABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.99
N/A
Current Price
$3.12
Company Overview
Basic Information| Metric | QNCX | FABC |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 16.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | QNCX | FABC |
|---|---|---|
| Price | $0.99 | $3.12 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 466.1K | ★ 542.7K |
| Earning Date | 04-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $2.81 |
| 52 Week High | $4.55 | $3.78 |
Technical Indicators
Market Signals| Indicator | QNCX | FABC |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | N/A |
| Support Level | $0.88 | N/A |
| Resistance Level | $0.98 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 62.13 | 0.00 |
Price Performance
Historical Comparison QNCX
FABC
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.